Todd C. Lee Md Mph Fidsa
Clinical trials sponsored by Todd C. Lee Md Mph Fidsa, explained in plain language.
-
Head-to-Head antibiotic showdown for dangerous blood infections
Disease control Recruiting nowThis study aims to find out which of two common antibiotics works better for treating serious MRSA bloodstream infections. It will enroll 300 patients and directly compare daptomycin against vancomycin. The main goal is to see which drug leads to better overall patient outcomes, …
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Heart valve infection study questions standard antibiotic
Disease control Recruiting nowThis study aims to find out if doctors can safely skip the antibiotic rifampin when treating serious Staph infections on artificial heart valves. It will compare outcomes for 330 patients who either receive or do not receive rifampin alongside standard treatment. The goal is to s…
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could a lower dose of a common drug fight pneumonia with fewer side effects?
Disease control Recruiting nowThis study is testing if a lower dose of the standard antibiotic treatment for Pneumocystis pneumonia (PCP) works as well as the current higher dose but causes fewer serious side effects. It will enroll over 400 immunocompromised adults with PCP. The goal is to find a safer, equa…
Phase: PHASE3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Two-Drug attack on deadly blood infection enters human trials
Disease control Recruiting nowThis study is testing if adding a second antibiotic called ertapenem to the standard treatment (cefazolin) works better for adults with a serious Staphylococcus aureus blood infection. The goal is to help patients clear the infection from their blood faster, which could improve s…
Phase: PHASE2 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Heart pill may fight deadly blood infection
Disease control Recruiting nowThis study is testing if switching from aspirin to a different blood thinner, clopidogrel, helps patients recover better from serious Staphylococcus aureus (Staph) bloodstream infections. It will enroll 300 patients who are already taking aspirin to prevent heart problems. Resear…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC